AMSBIO's Partner ScreenIn3D Wins Technology Innovation Prize

ScreenIn3D, a partner of AMSBIO, has received a share of the £1 million plus prize pot and will receive ongoing support from partners of Scottish Edge - a respected regional business support agency.

Scottish EDGE (https://www.scottishedge.com/) runs a competition aimed at identifying and supporting Scotland’s up-and-coming, innovative, high-growth potential entrepreneurial talent. The winning businesses for the latest Round 14 awards came from 37 multisector finalists, shortlisted from more than 280 applicants, who pitched their business idea live at Glasgow’s Technology and Innovation Centre and Edinburgh’s RBS Conference Centre on the 28th and 30th of May 2019.

Dr Michele Zagnoni, Chief Scientific Officer of ScreenIn3D said "We are delighted to have received this important innovation prize that recognises the groundbreaking screening services that we are able to provide to help drug developers validate the effectiveness of their compounds". He added "Combining the latest advances in microfluidics and 3D culture in a unique screening platform, the service we provide has already shown real benefits to organisation developing improved anticancer drug treatments, helping them to accelerate the introduction of personalised medicine solutions for this important area".

Over the past 10 years, 3D in vitro and ex vivo assay platforms using scaffolds, extracellular matrices (ECM) and scaffold / ECM-free formats have been increasingly used to create physiologically relevant models of organs and diseases. Such models have been extensively used as tools for analysis of drug activity response and monitoring potential changes at subcellular levels, to identify downstream targets post drug treatment. The cell response to drug treatment is not just determined by the inherent characteristics of the target cell, but is also influenced and at times controlled by signals derived from other cells and tissue type (such as stroma, fibroblasts, distinct immune cell compartments) either within the tumor microenvironment or the organ microenvironment. This characteristic makes finding effective therapy very difficult if the in vitro model does not recapitulate the in vivo components that mediate drug mechanisms of action.

ScreenIn 3D's innovative screening service combines the latest advances in microfluidics and cell culture to enable life scientists to study the effect of drugs on various cell types as well as their interactions in a 3D microenvironment.

For further information please visit https://screenin3d.com or contact partner AMSBIO on 44-1235-828200/+1-617-945-5033 / info@amsbio.com. 

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.

For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.  

Worldwide HQ 

AMS Biotechnology (AMSBIO)

184 Milton Park
Abingdon

Oxon OX14 4SE

UK
Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com 
Web www.amsbio.com

 

North American HQ

 

AMSBIO LLC
1035 Cambridge Street
Cambridge
MA 02141
USA
Tel: +1.617.945.5033 
Tel: +1.800.987.0985 (toll free)
Email: info@amsbio.com 
Web www.amsbio.com